Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 19 stocks, with a combined market cap of $3,197.16 billion, total revenue of $676.65 billion and a weighted average PE ratio of 35.07.

Market Cap
3,197.16B
Revenue
676.65B
Profits
91.16B
PE Ratio
35.07
Profit Margin
13.47%
Dividend Yield
2.19%

19 Stocks

No. Symbol Company Name Market Cap % Change Volume Revenue
1LLYEli Lilly and Company678.39B3.25%5,135,90340.86B
2NVONovo Nordisk A/S462.22B2.57%7,509,74440.47B
3JNJJohnson & Johnson368.63B0.07%5,698,14987.70B
4ABBVAbbVie Inc.296.46B0.71%3,019,16755.53B
5MRKMerck & Co., Inc.246.49B0.93%7,722,82563.17B
6NVSNovartis AG205.45B-0.17%971,63549.94B
7AZNAstraZeneca PLC195.32B-0.94%6,054,02251.21B
8AMGNAmgen Inc.154.74B2.83%4,229,85432.53B
9PFEPfizer Inc.141.33B-0.64%40,569,90859.38B
10SNYSanofi119.69B-0.46%1,253,58054.03B
11BMYBristol-Myers Squibb Company117.39B-0.60%8,405,14347.44B
12GILDGilead Sciences, Inc.110.34B1.00%4,549,82728.30B
13GSKGSK plc67.04B-0.33%7,165,07141.97B
14BIIBBiogen Inc.22.73B0.37%1,560,6029.61B
15GRFSGrifols, S.A.6.84B1.65%625,2307.81B
16OGNOrganon & Co.3.79B0.96%2,308,0316.41B
17AMRNAmarin Corporation plc203.37M0.75%1,565,382241.02M
18SCLXScilex Holding Company74.37M-13.29%2,469,26050.83M
19MIRAMIRA Pharmaceuticals, Inc.20.95M-9.64%682,372-